We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
-2.4%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
AUM
$5.32B
AUM Growth
-$216M
Cap. Flow
-$62.5M
Cap. Flow %
-1.18%
Top 10 Hldgs %
23.94%
Holding
294
New
29
Increased
89
Reduced
98
Closed
32

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$46.6M
2
GILD icon
Gilead Sciences
GILD
+$37M
3
BCR
CR Bard Inc.
BCR
+$31.1M
4
CVS icon
CVS Health
CVS
+$27.8M
5
DHR icon
Danaher
DHR
+$26.6M

Sector Composition

Rank Sector Weight
1 Technology 24.2%
2 Healthcare 23.21%
3 Financials 21.91%
4 Communication Services 9.94%
5 Industrials 5.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACM icon
26
Aecom
ACM
$9.07B
$56.3M 1.06%
1,828,551
-2,542
-0.1% -$70.5K
BAH icon
27
Booz Allen Hamilton
BAH
$8.7B
$55.5M 1.04%
1,833,017
-2,911
-0.2% -$83K
SU icon
28
Suncor Energy
SU
$77.7B
$53M 1%
1,643,662
+280,923
+21% +$6.8M
AMZN icon
29
Amazon
AMZN
$2.5T
$51.4M 0.97%
1,733,060
+168,040
+11% +$4.77M
TEL icon
30
TE Connectivity
TEL
$58.8B
$50.8M 0.95%
819,676
-1,248
-0.2% -$72.5K
AON icon
31
Aon
AON
$77.3B
$49.8M 0.94%
476,852
-753
-0.2% -$70.6K
ICLR icon
32
Icon
ICLR
$12.8B
$49.7M 0.94%
661,931
-903
-0.1% -$63.3K
EBAY icon
33
eBay
EBAY
$48.6B
$48.5M 0.91%
2,032,439
+579,060
+40% +$14.1M
UNP icon
34
Union Pacific
UNP
$183B
$48M 0.9%
+603,004
New +$46.6M
BABA icon
35
Alibaba
BABA
$269B
$46.8M 0.88%
592,220
+759
+0.1% +$53.4K
TEVA icon
36
Teva Pharmaceuticals
TEVA
$35.9B
$46.2M 0.87%
862,567
+125,967
+17% +$7.39M
BAC icon
37
Bank of America
BAC
$435B
$44.4M 0.83%
3,282,089
+249,062
+8% +$3.36M
GILD icon
38
Gilead Sciences
GILD
$161B
$43.6M 0.82%
475,052
+410,332
+634% +$37M
MRSH
39
Marsh
MRSH
$86.3B
$42.2M 0.79%
695,000
-5,000
-0.7% -$280K
CCL icon
40
Carnival Corporation Ltd
CCL
$36.1B
$41.5M 0.78%
786,789
-445,283
-36% -$21.5M
SYK icon
41
Stryker
SYK
$127B
$40.2M 0.76%
375,002
-13,445
-3% -$1.33M
ORCL icon
42
Oracle
ORCL
$331B
$40.2M 0.76%
982,225
-43,738
-4% -$1.62M
SPLK
43
DELISTED
Splunk Inc
SPLK
$38.7M 0.73%
791,370
+179,043
+29% +$8.06M
MCK icon
44
McKesson
MCK
$98.5B
$38.7M 0.73%
245,834
-6,751
-3% -$1.09M
WCN
45
Waste Connections
WCN
$42.8B
$35M 0.66%
812,682
-674,175
-45% -$27.2M
LAZ icon
46
Lazard
LAZ
$4.37B
$33.7M 0.63%
868,599
-91,153
-9% -$3.27M
TMO icon
47
Thermo Fisher Scientific
TMO
$211B
$33.3M 0.63%
235,046
+9,462
+4% +$1.27M
UNH icon
48
UnitedHealth
UNH
$382B
$32.7M 0.61%
253,539
-71,961
-22% -$8.51M
CVS icon
49
CVS Health
CVS
$137B
$31.4M 0.59%
302,347
+285,847
+1,732% +$27.8M
PFPT
50
DELISTED
Proofpoint, Inc.
PFPT
$29.1M 0.55%
541,762
+183,785
+51% +$9.37M

Similar funds

Polar Capital's Q1 2016 Portfolio in Review

As of Q1 2016, Polar Capital held 294 positions worth $5.32B, down 3.9% from $5.53B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital's Q1 2016 filing shows 29 new, 89 increased, 98 reduced and 32 closed positions. Its largest new stake was Union Pacific: 603,004 shares worth $48M. The largest sale was Bristol-Myers Squibb, an estimated $36.5M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Polar Capital's largest Q1 2016 buy was Union Pacific: 603,004 shares worth $48M.
  • Polar Capital added most to Gilead Sciences in Q1 2016, an estimated $37M increase.
  • Polar Capital's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $36.5M.
  • Polar Capital fully exited Centene in Q1 2016, selling an estimated $27.3M.
  • Polar Capital's ten largest holdings make up 24% of its $5.32B portfolio in Q1 2016.
  • Polar Capital opened 29 new positions and closed 32 in Q1 2016.
  • Polar Capital's portfolio value fell 3.9% quarter-over-quarter to $5.32B.

Based on Polar Capital's 13F filing for Q1 2016, filed 16 May 2016.